查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370391

自体免疫疾病诊断市场：2023-2028年全球产业趋势、份额、规模、成长、机会与预测

Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年全球自体免疫疾病诊断市场规模达37亿美元。展望未来，IMARC集团预计到2028年市场规模将达到53亿美元，2023-2028年复合年增长率（CAGR）为5.8%。自体免疫疾病发生率的增加、保单销售的增加以及电子病历的使用不断增加是推动市场发展的一些关键因素。

自体免疫疾病是一组免疫系统攻击身体细胞、组织和器官的疾病。它可能由不同的疾病引起，例如係统性红斑狼疮 (SLE)、多发性硬化症、类风湿性关节炎和 I 型糖尿病。它与疲劳、关节疼痛和僵硬、皮疹、发烧和消化问题有关。它还会对器官和组织造成损害，从而导致更严重的症状，如呼吸困难、器官衰竭，甚至死亡。它可以透过多种方法的组合来诊断，例如获取详细的病史、进行体格检查、血液测试以检测特定抗体、成像测试以寻找损伤或炎症，以及活组织检查以在一定条件下检查受影响的组织。显微镜。

自体免疫疾病诊断市场趋势：

自体免疫疾病在个体中的发生率激增，以及容易患此类疾病的人口老化不断增加，是推动全球自体免疫疾病诊断需求的主要因素之一。此外，人们对自体免疫疾病及其症状、诊断和治疗选择的便利性的认识不断提高，有利于市场的成长。此外，为自体免疫疾病的诊断或治疗提供经济援助并降低整体医疗费用的健康保险政策的持续实施正在对市场产生积极影响。除此之外，一些国家的管理当局正在资助研究和开发（R&D）项目，以研究自体免疫疾病并开发新的治疗方法。他们还投资旨在开发改进这些疾病诊断方法的项目。除此之外，他们还采取倡议，为所有人提供优质的医疗保健设施。再加上诊断技术的显着改进，正在加强市场的成长。此外，随着医疗保健专业人员能够获取更全面的患者信息，电子病历 (EMR) 的使用越来越多，以提高自体免疫疾病诊断的准确性和速度。这加上远距医疗的日益普及，正在刺激对远距自体免疫疾病诊断和监测技术的需求。除此之外，对非侵入性诊断的需求不断增长，与传统诊断程序相比，非侵入性诊断的痛苦较小，正在为市场创造积极的前景。

本报告回答的关键问题

  • 全球自体免疫疾病诊断市场规模有多大？
  • COVID-19对全球自体免疫疾病诊断市场有何影响？
  • 全球自体免疫疾病诊断市场的预期成长率是多少？
  • 推动全球自体免疫疾病诊断市场的关键因素是什么？
  • 根据产品类型，全球自体免疫疾病诊断市场的细分情况如何？
  • 根据疾病类型，全球自体免疫疾病诊断市场的细分情况如何？
  • 根据测试类型，全球自体免疫疾病诊断市场的细分情况如何？
  • 全球自体免疫疾病诊断市场的重点区域有哪些？
  • 全球自体免疫疾病诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球自体免疫疾病诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 耗材和检测试剂盒
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测

第 7 章：依疾病类型分類的市场

  • 系统性自体免疫疾病
    • 市场走向
    • 按类型分類的市场细分
      • 类风湿关节炎
      • 牛皮癣
      • 系统性红斑狼疮 (SLE)
      • 多发性硬化症
      • 其他的
    • 市场预测
  • 局限性自体免疫疾病
    • 市场走向
    • 按类型分類的市场细分
      • 发炎性肠道疾病
      • 1 型糖尿病
      • 甲状腺
      • 其他的
    • 市场预测

第 8 章：按测试类型分類的市场

  • 常规实验室测试
    • 市场走向
    • 市场预测
  • 发炎标记物
    • 市场走向
    • 市场预测
  • 自体抗体和免疫学测试
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 临床实验室
    • 市场走向
    • 市场预测
  • 医院
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AESKU.GROUP
    • Danaher Corp.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • PerkinElmer Inc.
    • Hemagen Diagnostics, Inc.
    • Inova Diagnostics, Inc.
    • Myriad Genetics, Inc.
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG
    • SQI Diagnostics
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech plc
Product Code: SR112023A2250

Abstract

Market Overview:

The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent some of the key factors driving the market.

An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems. It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.

Autoimmune Disease Diagnosis Market Trends:

The surging incidences of autoimmune diseases among individuals and the increasing aging population that are susceptible to develop such medical conditions represent one of the major factors driving the demand for autoimmune disease diagnosis around the world. Moreover, the rising awareness about autoimmune disease, its symptoms, diagnosis, and the easy availability of the treatment options is favoring the growth of the market. In addition, the growing implementation of health insurance policies that offer financial assistance for autoimmune disease diagnosis or treatment and reduce overall medical expenses is influencing the market positively. Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market. Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, disease type, test type and end-user.

Product Type Insights:

Consumables and Assay Kits

Instruments

The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the product type. This includes consumables and assay kits, and instruments. According to the report, consumables and assay kits represented the largest segment.

Disease Type Insights:

Systemic Autoimmune Disease

Rheumatoid Arthritis

Psoriasis

Systemic Lupus Erythematosus (SLE)

Multiple Sclerosis

Others

Localized Autoimmune Disease

Inflammatory Bowel Disease

Type 1 Diabetes

Thyroid

Others

A detailed breakup and analysis of the autoimmune disease diagnosis market based on the disease type has also been provided in the report. This includes systemic autoimmune disease (rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), multiple sclerosis, and others) and localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others). According to the report, localized autoimmune disease (inflammatory bowel disease, type 1 diabetes, thyroid, and others) accounted for the largest market share.

Test Type Insights:

Routine Laboratory Tests

Inflammatory Markers

Autoantibodies and Immunologic Tests

Others

The report has provided a detailed breakup and analysis of the autoimmune disease diagnosis market based on the test type. This includes routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and others. According to the report, routine laboratory tests represented the largest segment.

End-User Insights:

Clinical Laboratories

Hospitals

Others

A detailed breakup and analysis of the autoimmune disease diagnosis market based on the end-user has also been provided in the report. This includes clinical laboratories, hospitals, and others. According to the report, clinical laboratories accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for autoimmune disease diagnosis. Some of the factors driving the North America autoimmune disease diagnosis market included the easy availability of treatments, technological advancements, extensive research and development (R&D) projects, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global autoimmune disease diagnosis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMerieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What is the size of the global autoimmune disease diagnosis market?
  • 2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
  • 3. What is the expected growth rate of the global autoimmune disease diagnosis market?
  • 4. What are the key factors driving the global autoimmune disease diagnosis market?
  • 5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
  • 6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
  • 7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
  • 8. What are the key regions in the global autoimmune disease diagnosis market?
  • 9. Who are the key players/companies in the global autoimmune disease diagnosis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autoimmune Disease Diagnosis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables and Assay Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease Type

  • 7.1 Systemic Autoimmune Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Rheumatoid Arthritis
      • 7.1.2.2 Psoriasis
      • 7.1.2.3 Systemic Lupus Erythematosus (SLE)
      • 7.1.2.4 Multiple Sclerosis
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Localized Autoimmune Disease
    • 7.2.1 Market Trends
    • 7.2.2 Market Breakup by Type
      • 7.2.2.1 Inflammatory Bowel Disease
      • 7.2.2.2 Type 1 Diabetes
      • 7.2.2.3 Thyroid
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Routine Laboratory Tests
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Inflammatory Markers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoantibodies and Immunologic Tests
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Clinical Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AESKU.GROUP
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Danaher Corp.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 bioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PerkinElmer Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hemagen Diagnostics, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Inova Diagnostics, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Myriad Genetics, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 SQI Diagnostics
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Trinity Biotech plc
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Autoimmune Disease Diagnosis Market: Major Drivers and Challenges
  • Figure 2: Global: Autoimmune Disease Diagnosis Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Autoimmune Disease Diagnosis Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Autoimmune Disease Diagnosis Market: Breakup by Disease Type (in %), 2022
  • Figure 5: Global: Autoimmune Disease Diagnosis Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: Autoimmune Disease Diagnosis Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Autoimmune Disease Diagnosis Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Autoimmune Disease Diagnosis (Consumables and Assay Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Autoimmune Disease Diagnosis (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Autoimmune Disease Diagnosis (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
  • Figure 15: Global: Autoimmune Disease Diagnosis (Systemic Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market: Breakup by Disease Type (in %), 2022
  • Figure 18: Global: Autoimmune Disease Diagnosis (Localized Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Autoimmune Disease Diagnosis (Routine Laboratory Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Autoimmune Disease Diagnosis (Inflammatory Markers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Autoimmune Disease Diagnosis (Autoantibodies and Immunologic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Autoimmune Disease Diagnosis (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Autoimmune Disease Diagnosis (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Autoimmune Disease Diagnosis (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Autoimmune Disease Diagnosis (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Autoimmune Disease Diagnosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Autoimmune Disease Diagnosis (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Autoimmune Disease Diagnosis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia Pacific: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia Pacific: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Autoimmune Disease Diagnosis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Autoimmune Disease Diagnosis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Autoimmune Disease Diagnosis Industry: SWOT Analysis
  • Figure 82: Global: Autoimmune Disease Diagnosis Industry: Value Chain Analysis
  • Figure 83: Global: Autoimmune Disease Diagnosis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autoimmune Disease Diagnosis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 4: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Autoimmune Disease Diagnosis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Autoimmune Disease Diagnosis Market Structure
  • Table 8: Global: Autoimmune Disease Diagnosis Market: Key Players